---
title: "Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response"
nct_id: NCT02559726
overall_status: COMPLETED
phase: NA
sponsor: University Hospital, Bordeaux
study_type: INTERVENTIONAL
primary_condition: Hypertrophic Cardiomyopathy
countries: France
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02559726.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02559726"
ct_last_update_post_date: 2022-02-14
last_seen_at: "2026-05-12T06:45:22.284Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response

**Official Title:** Identification and Quantification of a Mechanical Hyper-synchronicity State in Hypertrophic Cardiomyopathy (HCM) With Left Outflow-tract Obstruction and Description of Its Electrical and Electro-mechanical Characteristics Thanks to an Innovative Multi-imaging Approach to Predict a Positive Response to Dual Chamber Pacing. The Hsync Study.

**NCT ID:** [NCT02559726](https://clinicaltrials.gov/study/NCT02559726)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 60
- **Lead Sponsor:** University Hospital, Bordeaux
- **Conditions:** Hypertrophic Cardiomyopathy, Mechanical Hyper-synchronicity
- **Start Date:** 2015-06-22
- **Completion Date:** 2019-01-19
- **CT.gov Last Update:** 2022-02-14

## Brief Summary

Hypertrophic cardiomyopathy (HCM) is a common genetic cardiovascular disease. Outflow-tract gradient of 30 mmHg or more under resting conditions is an independent determinant of symptoms of progressive heart failure and death.

The investigators hypothesize that the electrical approach by dual chamber pacing could improve symptoms and reduce outflow-tract obstruction in a specific sub-group of selected patients with a mechanical hyper-synchronicity. The aim of the study is to identify and describe this phenomenon in HCM with (O-HCM) and without (NO-HCM) outflow-tract obstruction thanks to innovative multi-imaging approach.

## Detailed Description

The concept of physiological ventricular desynchrony was described recently with technics of myocardial deformation analysis applied in animal models. Authors confirmed the existence of a time delay in the contraction of the apical walls before basal walls. In O-HCM, the outflow-tract obstruction could be explained by a mechanical hyper-synchronicity between apical and basal walls. This study aims to describe the possible hyper-synchronized contraction in O-HCM and NO-HCM patients unlike the physiological desynchrony observed in healthy volunteers (HV) For this purpose, three imaging tests will be used at baseline: echocardiography (TEE), magnetic resonance imaging (MRI) with gadolinium enhancement only in HCM, and 3-dimensional electrocardiographic mapping (ECM) combined with computed tomography-scan. No follow-up is planned for this study.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* HCM: Adults aged more than 18 years with sarcomeric hypertrophic cardiomyopathy under optimal medical therapy, isolated septal hypertrophy, sinus rhythm, exploitable acoustic window. For women of childbearing age, effective contraception and required negative pregnancy test.
* O-HCM : outflow-tract gradient more than 30 mmHg at rest and during exercise
* NO-HCM : outflow-tract gradient less than 30 mmHg at rest and during exercise
* HV: Adults aged more than 18 years, without cardiovascular disease. For women of childbearing age, effective contraception and required negative pregnancy test.

Exclusion Criteria:

\- HV: unusable acoustic window
```

## Arms

- **O-HCM** (EXPERIMENTAL) — 20 patients with Hypertrophic Cardiomyopathy with outflow-tract obstruction
- **NO-HCM** (EXPERIMENTAL) — 20 patients with Hypertrophic Cardiomyopathy without outflow-tract obstruction
- **healthy volunteers** (OTHER) — 20 healthy volunteers

## Interventions

- **Echocardiography (TEE)** (PROCEDURE)
- **Magnetic resonance imaging (MRI) with gadolinium enhancement** (DEVICE)
- **Magnetic resonance imaging (MRI) without gadolinium enhancement** (DEVICE)
- **3D electrocardiographic mapping (ECM)** (PROCEDURE)

## Primary Outcomes

- **Mechanical time delay in contraction between basal and apical walls in TEE and MRI in O-HCM, NO-HCM and healthy volunteers** _(time frame: Day 1)_ — The main interest variable is the delay value (ms) of the contraction between basal and apical walls measured by TEE and MRI.

## Secondary Outcomes

- **Relationship between each mesure with hyper-synchronicity and outflow-tract gradient** _(time frame: Day 1)_
- **Electrical time delay in ECM between basal and apical walls and relationship with hyper-synchronicity and outflow tract gradient.** _(time frame: Day 1)_
- **Mechanical time delay between septal and lateral walls in MRI and TEE.** _(time frame: Day 1)_
- **Evolution of mechanical time delay between basal and apical walls at rest and exercise in O-HCM and NO-HCM and relationship with outflow-tract gradient.** _(time frame: Day 1)_
- **Delay between peaks of basal and apical radial displacement in MRI** _(time frame: Day 1)_
- **Delay between the beginning of the apical and basal radial displacement in MRI** _(time frame: Day 1)_
- **Apical-basal phase on a phase analysis of the radial displacement data in MRI** _(time frame: Day 1)_
- **Delay between apical and basal peaks circumferential strain in MRI** _(time frame: Day 1)_
- **Delay between the beginning of the apical and basal circumferential deformation in MRI** _(time frame: Day 1)_
- **Twist angle between the base and the apex in MRI** _(time frame: Day 1)_

## Locations (1)

- CHU de Bordeaux, Bordeaux, France

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.chu de bordeaux|bordeaux||france` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02559726.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02559726*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*